Womens leadership group announces new board members, 2016 programming

Article

WVLDI anticipates leadership change, educational opportunities next year.

The Women's Veterinary Leadership Development Initiative (WVLDI) has appointed three new members to its board of directors. They are:

  • Dr. Lisa Greenhill, associate executive director for institutional research and diversity at the American Association of Veterinary Medical Colleges (AAVMC)

  • Dr. Kathleen Ruby, director of counseling and wellness skills development at the Washington State University College of Veterinary Medicine

  • Dr. Lorrie Gaschen, associate dean for diversity and faculty affairs and professor and section chief of diagnostic imaging at the Louisiana State University School of Veterinary Medicine.

Dr. Karen Bradley“We are excited to expand the WVLDI's focus on wellness and diversity through the appointments of Drs. Greenhill, Ruby and Gaschen,” says WVLDI President Karen Bradley, DVM, in a release from the organization.

Stacy Pritt, DVM, WVLDI's president-elect, says individuals are invited to join the board of directors based on their experience, expertise and desire to work with others to see all veterinarians achieve their potential while working to promote female leaders in the profession.

Dr. Stacy PrittAll new board of director terms will start on January 1, 2016, which is when Pritt will begin her tenure as president and Rachel Cezar, DVM, will begin serving as president-elect. Pritt and Cezar are active within the American Veterinary Medical Association (AVMA) and other veterinary medical organizations.

In January, the WVLDI will make presentations at the AVMA Veterinary Leadership Conference. This will be followed by educational sessions at the Western Veterinary Conference and AAVMC Annual Conference in March and the AVMA National Convention in August. The organization will be presenting sessions at the CVC veterinary conferences in 2016 as well.

Related Videos
NAVC Gives
NAVC CEO Gene O'Neill
Co-founders of AAVMP
Stéphie-Anne Dulièpre
Related Content
© 2024 MJH Life Sciences

All rights reserved.